UNH - Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018
2024-04-01 12:43:16 ET
Summary
- Cigna's Evernorth Services segment, fueled by the acquisition of Express Scripts in 2018, is well positioned to benefit from innovation in drugs and specialty pharmacy.
- The company's management prioritizes shareholder returns and has infused growth into its outlook, inspiring investors.
- Cigna's outlook and investor day presentation suggests it can reach a target of $400+ and has strong growth potential.
Investment Thesis
Cigna Healthcare ( CI ) recently concluded its 2024 Investor Day, and management's guidance continues to showcase how they prioritize shareholder returns, in my opinion. After an uninspiring performance in the markets through 2023, management looks to have pulled all the right levers recently to infuse growth into its outlook and inspire investors along the way....
Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018